Cardio Care offers the Injectomat TIVA Agilia is an innovative standalone anesthesia syringe pump. Injectomat TIVA Agilia has featured a 0.1-1200 ml/h flow rate and 5,10, 20, 30/35, 50/60 CC syringe capacities. The device boasts a wide range of infusion modes to include dose rate, ml/h, 24h / h / min, and a 0.1-999.9 ml volume limit. The Injectomat TIVA Agilia is a class-leading anesthesia system that is perfectly suited for Sufentanil in plasma, Propofol, or Remifentanil modes.
- Features:
- Flow rate range: 0.1-1200 ml/h (depending on the syringe capacity).
- Flow rate accuracy: ± 1% on mechanism; ± 2 % on syringes.
- Syringe capacities: 5,10, 20, 30/35, 50/60 CC.
- Infusion modes
- ml/h.
- Dose rate.
- Dose units: ng, μg, mg, cal, kcal, U, kU, mmol, mol, Kmol / kg.
- Time units: 24h / h / min.
- Dilution setting: X units / ml or X units / Y ml.
- Volume or dose / time: 0.1-99.9 units ; 00h01- 96h00.
- Volume limit: 0.1-999.9 ml.
- TCI Functions: Injectomat® TIVA Agilia is an IV anaesthesia system incorporating pharmacokinetics models for Propofol,
- Remifentanil, Sufentanil in plasma or effect mode.
- Bolus: Manual bolus: Rate: 50 -1200 ml/h; 50 ml/h increment. Programmed bolus (dose or volume/time): 0.1-99.9 units / 0.1-
- 1200 ml/time auto-calculation.
Programming modes: No drug names: infusion without any display of the drug names. Drug labelling: infusion with the drug names. Vigilant® Drug’Lib: the secured IV Administration mode with a drug library.
Drug labelling: Display of the drug name based on a list of 50 pre-set drug names.
Drug libraries: Drug parameters, infusion, bolus and loading dose parameters, authorised infusion modes, infusion mode per default. Inititial drug library of 50 drugs adjustable with Vigilant®, the IV Medication Safety Solution. Up to 120 drugs (depending on comment size) storable in 4 different drug libraries.
Pressure modes: 2 modes available: variable or 3 pre-set levels – From 100 to 900 mmHg, 50 mmHg increment.
DPS The Dynamic Pressure System – DPS – warns of pressure variations. A risk of obstruction or a possible leak in the infusion line can thus be anticipated.
Anti-bolus system: Reduces significantly bolus after occlusion release (0.2 ml max).
Manufactured By:
Fresenius Kabi
